Asthma predictive factors in infants with bronchiolitis: asthma risk at 13-20 years of age.

biodegradable nanoparticles for aerosol therapy based on the branched polyesters, DEAPA-PVAL-g-PLGA. Pharm Res 2003; 20: 2011–2020. 17 Grenha A, Seijo B, Remunan-Lopez C. Microencapsulated chitosan nanoparticles for lung protein delivery. Eur J Pharm Sci 2005; 25: 427–437. 18 Shi LJ, Plumley CJ, Berkland C. Biodegradable nanoparticle flocculates for dry powder aerosol formulation. Langmuir 2007; 23: 10897–10901. 19 Zhang Q, Shen ZC, Nagai T. Prolonged hypoglycemic effect of insulin-loaded polybutylcyanoacrylate nanoparticles after pulmonary administration to normal rats. Int J Pharm 2001; 218: 75–80. 20 Pandey R, Sharma A, Zahoor A, et al. Poly (DL-lactide-co-glycolide) nanoparticle-based inhalable sustained drug delivery system for experimental tuberculosis. J Antimicrob Chemother 2003; 52: 981–986. 21 Bivas-Benita M, Romeijn S, Junginger HE, et al. PLGA-PEI nanoparticles for gene delivery to pulmonary epithelium. Eur J Pharm Biopharms 2004; 58: 1–6. 22 Gou ML, Zheng L, Peng XY, et al. Poly(epsilon-caprolactone)poly(ethylene glycol) -poly(epsilon-caprolactone) (PCL-PEG-PCL) nanoparticles for honokiol delivery in vitro. Int J Pharm 2009; 375: 170–176. 23 Khemtong C, Kessinger CW, Gao JM. Polymeric nanomedicine for cancer MR imaging and drug delivery. Chem Commun 2009; 3497–3510. 24 Patil YB, Toti US, Khdair A, et al. Single-step surface functionalization of polymeric nanoparticles for targeted drug delivery. Biomaterials 2009; 30: 859–866. 25 Beck-Broichsitter M, Gauss J, Packhaeuser CB, et al. Pulmonary drug delivery with aerosolizable nanoparticles in an ex vivo lung model. Int J Pharm 2009; 367: 169–178. 26 Abeylath SC, Turos E. Glycosylated polyacrylate nanoparticles by emulsion polymerization. Carbohydr Polym 2007; 70: 32–37. 27 Abeylath SC, Turos E, Dickey S, et al. Glyconanobiotics: Novel carbohydrated nanoparticle antibiotics for MRSA and Bacillus anthracis. Bioorg Med Chem 2008; 16: 2412–2418. 28 Turos E, Shim JY, Wang Y, et al. Antibiotic-conjugated polyacrylate nanoparticles: New opportunities for development of anti-MRSA agents. Bioorg Med Chem Lett 2007; 17: 53–56. 29 Turos E, Reddy GSK, Greenhalgh K, et al. Penicillin-bound polyacrylate nanoparticles: Restoring the activity of beta-lactam antibiotics against MRSA. Bioorg Med Chem Lett 2007; 17: 3468–3472. 30 Garay-Jimenez JC, Young A, Gergeres D, et al. Methods for purifying and detoxifying sodium dodecyl sulfate-stabilized polyacrylate nanoparticles. Nanomedicine 2008; 4: 98–105. 31 Greenhalgh K, Turos E. In vivo studies of polyacrylate nanoparticle emulsions for topical and systemic applications. Nanomedicine 2009; 5: 46–54. 32 Onizawa S, Aoshiba K, Kajita M, et al. Platinum nanoparticle antioxidants inhibit pulmonary inflammation in mice exposed to cigarette smoke. Pulm Pharmacol Ther 2009; 22: 340–349.